In vivo bioluminescent imaging of orthotopic tumors showed that silencing SATB2 dramatically inhibited GSC‐driven tumor growth in mouse brains (Fig 3A and B; Appendix Fig S3D and E). This evidence concerns the gene SATB2 and neoplasm.